• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Franklin Strategic Series - Franklin Biotechnology Discovery Fund

+ Add to Watchlist

FBDIX:US

141.71 USD 0.98 0.69%

As of 19:59:59 ET on 07/28/2014.

Snapshot for Franklin Strategic Series - Franklin Biotechnology Discovery Fund (FBDIX)

Year To Date: +8.14% 3-Month: +13.02% 3-Year: +31.86% 52-Week Range: 110.84 - 162.37
1-Month: -1.24% 1-Year: +22.17% 5-Year: +24.63% Beta vs SPX: 1.08

Mutual Fund Chart for FBDIX

No chart data available.
  • FBDIX:US 141.71
  • 1M
  • 1Y
Interactive FBDIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBDIX

Franklin Biotechnology Discovery Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The Fund invests a substantial portion of its assets in equity securities of smaller capitalization companies.

Inception Date: 09-15-1997 Telephone: 1-800-632-2301
Managers: EVAN MCCULLOCH / JEREL BANKS
Web Site: www.franklintempleton.com

Fundamentals for FBDIX

NAV (on 2014-07-28) 141.71
Assets (M) (on 2014-06-30) 1,332.47
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for FBDIX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2013-12-16) 1.58
Dividend Yield (ttm) 6.21

Fees & Expenses for FBDIX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 0.50
Redemption Fee 0.00
12b1 Fee 0.29
Expense Ratio 1.10

Top Fund Holdings for FBDIX

Filing Date: 03/31/2014
Name Position Value % of Total
Gilead Sciences Inc 1,915,800 135,753,588 9.328%
Biogen Idec Inc 353,261 108,051,942 7.425%
Amgen Inc 674,900 83,242,166 5.720%
Regeneron Pharmaceuticals Inc 251,009 75,372,983 5.179%
Celgene Corp 964,000 67,287,200 4.624%
Medivation Inc 995,454 64,077,374 4.403%
Illumina Inc 325,800 48,433,428 3.328%
Alexion Pharmaceuticals Inc 288,400 43,874,292 3.015%
Incyte Corp Ltd 779,100 41,697,432 2.865%
Vertex Pharmaceuticals Inc 469,600 33,210,112 2.282%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil